# | Title | Journal | Year | Citations |
---|
1 | How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study | BJU International | 2001 | 1,429 |
2 | The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences | BJU International | 1999 | 985 |
3 | Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction | BJU International | 2011 | 790 |
4 | The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study | BJU International | 2008 | 700 |
5 | The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing | BJU International | 1996 | 611 |
6 | The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study | BJU International | 2009 | 601 |
7 | The prevalence of urinary incontinence in women in four European countries | BJU International | 2004 | 599 |
8 | Robotically-assisted laparoscopic radical prostatectomy | BJU International | 2001 | 589 |
9 | Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial | BJU International | 1998 | 564 |
10 | Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion | BJU International | 2003 | 551 |
11 | Prognostic Gleason grade grouping: data based on the modified Gleason scoring system | BJU International | 2013 | 540 |
12 | The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus | BJU International | 2004 | 517 |
13 | The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer | BJU International | 2008 | 516 |
14 | A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution | BJU International | 2003 | 501 |
15 | Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial | BJU International | 2003 | 460 |
16 | Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function | BJU International | 1999 | 445 |
17 | Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome | BJU International | 2005 | 417 |
18 | Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis | BJU International | 2001 | 391 |
19 | Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group | BJU International | 2012 | 391 |
20 | The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health‐related quality of life, anxiety and depression: EpiLUTS | BJU International | 2009 | 371 |
21 | Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder | BJU International | 1998 | 368 |
22 | Oxidative stress, DNA damage and apoptosis in male infertility: a clinical approach | BJU International | 2005 | 362 |
23 | The prevalence of Peyronie's disease: results of a large survey | BJU International | 2001 | 358 |
24 | Anatomical studies of the neurovascular bundle and cavernosal nerves | BJU International | 2004 | 358 |
25 | Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons | BJU International | 2002 | 352 |
26 | Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder | BJU International | 2004 | 352 |
27 | Scarless single port transumbilical nephrectomy and pyeloplasty: first clinical report | BJU International | 2008 | 345 |
28 | Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection | BJU International | 2011 | 341 |
29 | Muscarinic receptor antagonists for overactive bladder | BJU International | 2007 | 339 |
30 | Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis | BJU International | 1997 | 337 |
31 | Patient‐reported reasons for discontinuing overactive bladder medication | BJU International | 2010 | 336 |
32 | Standardization and definitions in lower urinary tract dysfunction in children | BJU International | 1998 | 335 |
33 | Robotic single‐port transumbilical surgery in humans: initial report | BJU International | 2009 | 332 |
34 | An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011 | BJU International | 2013 | 323 |
35 | Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee | BJU International | 2004 | 322 |
36 | Is transurethral resection of the prostate still justified? | BJU International | 2001 | 318 |
37 | The impact on health-related quality of life of stress, urge and mixed urinary incontinence | BJU International | 2003 | 318 |
38 | The molecular basis of cryosurgery | BJU International | 2005 | 314 |
39 | The destruction of the lower urinary tract by ketamine abuse: a new syndrome? | BJU International | 2008 | 307 |
40 | Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials | BJU International | 2004 | 298 |
41 | Inflammation and prostate cancer: the role of interleukin 6 (IL‐6) | BJU International | 2014 | 295 |
42 | Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up | BJU International | 2006 | 294 |
43 | The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA | BJU International | 2003 | 293 |
44 | Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience | BJU International | 2012 | 286 |
45 | Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005 | BJU International | 2011 | 283 |
46 | Urethral strictures | BJU International | 2011 | 283 |
47 | What surgical resection margins are required to achieve oncological control in men with primary penile cancer? | BJU International | 2005 | 282 |
48 | The effect of age and gender on bladder cancer: a critical review of the literature | BJU International | 2010 | 281 |
49 | The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women | BJU International | 2003 | 278 |
50 | Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging | BJU International | 2011 | 278 |